Hydroxychloroquine in short supply, says FDA. 'Angry, disappointed and scared,' say lupus patients.

Deutschland Nachrichten Nachrichten

Hydroxychloroquine in short supply, says FDA. 'Angry, disappointed and scared,' say lupus patients.
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 USATODAY
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 63%

'I’m angry, disappointed, and scared': Lupus patients say they desperately need hydroxychloroquine and that has been in short supply.

on March 31, and supplies never caught up with demand, even after the initial explosion of orders eased.

Life without hydroxychloroquine is hard for lupus patients, who usually suffer from joint pain, severe fatigue, and rashes. The FDA has approved the drug for decreasing flare-ups of the disease. According to the Lupus Foundation of America, about 1.5 million Americans have a form of lupus, and 90% are women.

When the medication was available, “I was in less pain, I was able to cook dinner, I was able to clean up,” Rodriguez said. “Now I’m not on it, and I'm looking around my house, and I don't even know where and when I'm going to be able to pick up the pieces.”“I feel useless,” Rodriguez said.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

USATODAY /  🏆 100. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Birx: FDA 'has been very clear' on its concerns about using hydroxychloroquine as COVID-19 treatmentBirx: FDA 'has been very clear' on its concerns about using hydroxychloroquine as COVID-19 treatment'It clearly shows the comorbidity that puts individuals at more risk,' Dr. Birx said of the new study, referring to patients with underlying health conditions.
Weiterlesen »

FDA investigates lab as tens of thousands of COVID-19 test results in Florida are questionedFDA investigates lab as tens of thousands of COVID-19 test results in Florida are questionedFederal regulators are investigating a Texas laboratory that a Florida hospital chain dropped last week because of delayed and unreliable COVID-19 test results.
Weiterlesen »

'This is a bad practice': Doctors question FDA protocol for plasma treatment of coronavirus patients'This is a bad practice': Doctors question FDA protocol for plasma treatment of coronavirus patientsThe story of convalescent plasma is one of a federal medical establishment wanting badly to compensate for its slow response to the coronavirus.
Weiterlesen »

FDA investigates lab as tens of thousands of COVID-19 test results in Florida are questionedFDA investigates lab as tens of thousands of COVID-19 test results in Florida are questionedThe dispute is expected to affect testing across the U.S. and also raises questions about how regulators and hospitals approve and choose labs.
Weiterlesen »

Coronavirus patients treated with Trump-touted hydroxychloroquine at higher risk of death, new study saysCoronavirus patients treated with Trump-touted hydroxychloroquine at higher risk of death, new study saysPatients who took the drug or chloroquine, which hydroxychloroquine is derived from, were also more likely to developed irregular heart rhythms.
Weiterlesen »



Render Time: 2025-03-21 22:53:54